Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus
Authors
Keywords
Regulatory T cells, Lymphocytes, NK cells, Systemic lupus erythematosus, B cells, Cytotoxic T cells, T helper cells, Lupus nephritis
Journal
PLoS One
Volume 17, Issue 2, Pages e0263536
Publisher
Public Library of Science (PLoS)
Online
2022-02-08
DOI
10.1371/journal.pone.0263536
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus
- (2021) James Greenan-Barrett et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Systemic Lupus Erythematosus Infection Predictive Index (LIPI): A Clinical-Immunological Tool to Predict Infections in Lupus Patients
- (2019) Jiram Torres-Ruiz et al. Frontiers in Immunology
- Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression
- (2019) Asmaa M. Zahran et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Altered peripheral lymphocyte subsets in untreated systemic lupus erythematosus patients with infections
- (2019) Zhimin Lu et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Regulatory T cells: the future of autoimmune disease treatment
- (2019) Monika Ryba-Stanisławowska et al. Expert Review of Clinical Immunology
- Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options
- (2019) Eve Mary Dorothy Smith et al. CLINICAL IMMUNOLOGY
- Age‐related changes in lymphocyte subpopulations in healthy Thai children
- (2019) Butsabong Lerkvaleekul et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus
- (2018) Masayuki Mizui et al. Frontiers in Immunology
- The Proportion of Regulatory T Cells in Patients with Systemic Lupus Erythematosus: A Meta-Analysis
- (2018) Sheng-Xiao Zhang et al. Journal of Immunology Research
- Increased CD4+CD25-Foxp3+ T cells in Chinese systemic lupus erythematosus: correlate with disease activity and organ involvement
- (2018) Z-J Yin et al. LUPUS
- Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective
- (2017) Vaishali R. Moulton et al. TRENDS IN MOLECULAR MEDICINE
- A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
- (2016) Ronald van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- CD4+CD25+CD127− and CD4+CD25+Foxp3+ Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients
- (2016) Marcelina Żabińska et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
- (2016) Jing He et al. NATURE MEDICINE
- New insights into the immunopathogenesis of systemic lupus erythematosus
- (2016) George C. Tsokos et al. Nature Reviews Rheumatology
- Association of γδ T Cell Compartment Size to Disease Activity and Response to Therapy in SLE
- (2016) Hongshuang Ma et al. PLoS One
- Regulatory T cells in systemic lupus erythematosus
- (2014) Kim Ohl et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Paediatric-onset systemic lupus erythematosus
- (2013) Clara Malattia et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Interferon- Suppresses cAMP to Disarm Human Regulatory T Cells
- (2013) N. Bacher et al. CANCER RESEARCH
- Promotion and prevention of autoimmune disease by CD8+ T cells
- (2013) David M. Gravano et al. JOURNAL OF AUTOIMMUNITY
- CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice
- (2013) Olivia Weigert et al. ARTHRITIS RESEARCH & THERAPY
- Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
- (2012) Susan Manzi et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Activity of Childhood Lupus Nephritis is Linked to Altered T Cell and Cytokine Homeostasis
- (2012) Monika Edelbauer et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Downregulation of CD94/NKG2A Inhibitory Receptor on Decreased γδ T Cells in Patients with Systemic Lupus Erythematosus
- (2012) L. Wang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- A Molecular Basis for NKT Cell Recognition of CD1d-Self-Antigen
- (2011) Thierry Mallevaey et al. IMMUNITY
- Mechanisms of tissue injury in lupus nephritis
- (2011) Tamara K Nowling et al. ARTHRITIS RESEARCH & THERAPY
- Reduction in Tγδ cell numbers and alteration in subset distribution in systemic lupus erythematosus
- (2010) C. LUNARDI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Prognostic Impact of Atypical Presentation in Pediatric Systemic Lupus Erythematosus: Results from a Multicenter Study
- (2010) Andrea Taddio et al. JOURNAL OF PEDIATRICS
- Prevalence and burden of pediatric-onset systemic lupus erythematosus
- (2010) Sylvia Kamphuis et al. Nature Reviews Rheumatology
- Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus
- (2009) Yong-Wook Park et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus
- (2008) B Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-α–producing antigen-presenting cells
- (2008) Bing Yan et al. ARTHRITIS AND RHEUMATISM
- Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis
- (2008) J. Yates et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CD4+CD25+ regulatory T cells (TREG) in Systemic Lupus Erythematosus (SLE) patients: The possible influence of treatment with corticosteroids
- (2008) N.A. Azab et al. CLINICAL IMMUNOLOGY
- Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance
- (2008) MI Vargas-Rojas et al. LUPUS
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started